semaglutide news A network meta-analysis backed weight-loss benefits with several GLP-1 receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio Type 2 diabetes drug improves

As scientific understanding deepens and technology advances, the future of GLP-1 in weight management shines with promise, holding the potential to revolutionize the landscape of obesity treatment and offer new hope for millions striving to achieve healthier and sustainable weight loss goals

Referral to registered dietitians or diabetes educators strengthens outcomes

Weight regain usually happens when old habits return

Depending on the details of an individuals medical history, phentermine and Adderall could be prescribed concurrently, but another treatment option may be looked at first

Our model predicts a steady increase in the prevalence of NAFLD among US adults from 27.8% in 2020 to 34.3% by 2050